BMPR2 rs1085307157: Understanding Pulmonary Arterial Hypertension
The rs1085307157 variant is a specific genetic change located within the BMPR2 gene. This variant is associated with a predisposition to primary pulmonary arterial hypertension, a condition involving elevated blood pressure in the arteries of the lungs.
What each genotype means
Typical BMPR2 genotype
This genotype represents the common, non-pathogenic state for this specific location in the BMPR2 gene. It is not associated with the increased risk of pulmonary arterial hypertension linked to pathogenic variants in this gene. You should follow standard medical guidance for cardiovascular health.
This is the most common genotype found in the general population across all ancestries.
Increased pulmonary hypertension risk
This genotype indicates the presence of a pathogenic variant in the BMPR2 gene, which is a known genetic risk factor for heritable pulmonary arterial hypertension. Because this condition can have variable penetrance, carrying this variant does not guarantee the development of the disease, but it warrants consultation with a specialist to discuss appropriate screening or monitoring. Please discuss these findings with your healthcare provider or a genetic counselor.
This genotype is rare, as pathogenic variants in the BMPR2 gene are identified in a small percentage of the general population.
High-risk pathogenic genotype
This genotype indicates that both copies of the BMPR2 gene carry this pathogenic variant, which is strongly associated with an increased risk of developing pulmonary arterial hypertension. Clinical research indicates that BMPR2-related conditions are inherited in an autosomal dominant manner, and this variant is linked to potential vascular remodeling and right heart stress. It is essential to discuss this result with a cardiologist or a specialist in pulmonary hypertension for clinical evaluation.
This genotype is extremely rare in the general population.
What is the rs1085307157 Variant?
The rs1085307157 variant is a specific alteration in the DNA sequence of the BMPR2 gene. In genetics, an rsID (reference SNP cluster ID) is a unique label used by researchers to identify a specific location in the human genome. This particular variant is categorized as a health predisposition marker. It sits within the coding regions of the BMPR2 gene, which provides instructions for creating a protein essential for regulating cell growth and division. Because this variant is classified as rare, it is not commonly found in the general population. Geneticists study such variants to understand how minor changes in our DNA can influence the structure and function of critical biological pathways, particularly those involved in maintaining the integrity of blood vessels throughout the body.
The Role of the BMPR2 Gene
The BMPR2 gene encodes the bone morphogenetic protein receptor type II, a transmembrane protein that belongs to the TGF-beta superfamily. This receptor plays a vital role in signaling pathways that control the proliferation and survival of cells, particularly those lining the pulmonary arteries. When the BMPR2 protein functions correctly, it helps maintain the balance of cell growth in the vessel walls. However, when mutations occur in this gene, the signaling pathway can be disrupted. This disruption may lead to the abnormal proliferation of smooth muscle and endothelial cells, which can cause the pulmonary arteries to narrow or thicken. This structural change increases resistance to blood flow, leading to the sustained high blood pressure characteristic of pulmonary arterial hypertension.
Research and Clinical Associations
Scientific research has established a strong link between pathogenic variants in the BMPR2 gene and heritable pulmonary arterial hypertension. Studies indicate that heterozygous germline mutations—where one copy of the gene is altered—are found in a significant majority of individuals with a family history of the condition. While the evidence for the pathogenicity of specific variants like rs1085307157 is considered moderate to strong in clinical databases, it is important to note that the condition exhibits reduced penetrance. This means that not everyone who carries a pathogenic BMPR2 variant will develop the disease. Researchers continue to investigate why some carriers remain healthy while others develop symptoms, suggesting that additional genetic or environmental factors likely play a role in the onset and progression of the condition.
Population Frequency and Interpretation
The rs1085307157 variant is classified as rare across global populations. In genetic studies, rare variants are those that appear at a very low frequency in the general population, often making them difficult to study without large-scale genomic datasets. Because of its rarity, the specific impact of this variant is often assessed through clinical case studies and family-based research rather than broad population-wide statistics. It is essential to understand that having a rare variant does not equate to a diagnosis. Genetic information provides a piece of a larger puzzle regarding health risks. If you have concerns about your genetic profile or family history, it is important to consult with a qualified genetic counselor or a medical professional who can provide context based on your personal health history.
Navigating Genetic Information
Understanding your genetic makeup can be a powerful tool, but it must be approached with caution. Genetic variants like rs1085307157 are markers of predisposition, not definitive predictors of disease. You cannot use this information to self-diagnose or make medical decisions, such as starting or stopping treatments. If you have received genetic testing results indicating the presence of this variant, the most appropriate step is to discuss these findings with a clinician or a specialist in pulmonary medicine. They can help interpret the results in the context of your overall health, perform necessary clinical evaluations, and guide you through any recommended monitoring or management strategies. Always rely on professional medical advice rather than interpreting genetic data in isolation.
How common is this variant?
The rs1085307157 variant is documented as a rare genetic change, appearing at a very low frequency in global population databases.
Frequently asked questions
What is pulmonary arterial hypertension?
Pulmonary arterial hypertension is a condition characterized by high blood pressure in the arteries that carry blood from the heart to the lungs. This increased pressure makes it harder for the heart to pump blood, which can lead to symptoms like shortness of breath and fatigue.
Does having a BMPR2 variant mean I will get sick?
Not necessarily. Many BMPR2 variants exhibit reduced penetrance, meaning that even if you carry the variant, you may never develop the condition. Other factors, including additional genetic influences and environmental triggers, are likely involved.
How is this variant detected?
This variant is typically identified through clinical genetic testing, such as gene panel sequencing, which looks for mutations in genes known to be associated with specific conditions. Such testing is usually ordered by a physician or genetic counselor.
What should I do if I have this variant?
If you are aware that you carry this variant, you should consult with a medical professional or a genetic counselor. They can provide personalized guidance, discuss the implications for your health, and determine if any clinical monitoring is necessary.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1085307157?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BMPR2
This pathogenic variant in the BMPR2 gene is associated with a predisposition to primary pulmonary hypertension.
This pathogenic variant in the BMPR2 gene is associated with an increased risk of developing primary pulmonary hypertension.